Skip to main content

Stay informed

 

Participate in a study

UCI MIND is Orange County’s only state and federally-funded Alzheimer’s Disease Research Center (ADRC)

UCI MIND PODCAST

Carousel SliderCommentaryCommunity EventsCOVID-19In the NewsParticipants

MIND Matters | Quarterly Newsletter | Winter 2024

Message from the Director Dear Friends of UCI MIND, Happy New Year! We hope that 2024 is off to a positive start for you. As we embark upon a new year, UCI MIND and the field of Alzheimer’s disease and related dementias (ADRD) research are abuzz with excitement about progress made and opportunities to further advance our field.  At the end of 2023, we held our annual signature fundraising event, the December to Remember Gala. We honored Lauren Miller Rogen and Seth Rogen, the founders of Hilarity for Charity (HFC) and our partners in a program to mentor and inspire…
Megan
March 1, 2024
CommentaryCommunity EventsCOVID-19In the NewsParticipants

MIND Matters | Quarterly Newsletter | Winter 2023

Message from the Director Dear Friends of UCI MIND, Advances in the field of Alzheimer’s disease (AD) research and the contributions of UCI MIND investigators remain tremendously exciting. Two new drugs have been approved by the FDA (page 3). These approvals are believed by many to represent the dawn of a new age in AD research and treatment. Both drugs received accelerated approval and we await a decision from the FDA about “full approval” for lecanemab. If received, full approval could cause the Centers for Medicare and Medicaid Services to revisit their previous coverage decision about anti-amyloid antibody therapies. These…
Megan
March 30, 2023
CommentaryCommunity EventsCOVID-19In the NewsParticipants

MIND Matters | Quarterly Newsletter | Fall 2022

Message from the Director Dear Friends of UCI MIND, As the fall MIND Matters newsletter goes to print, many of us are preparing to travel to San Francisco for the annual Clinical Trials in Alzheimer’s Disease (CTAD) meeting, where we will hear important results from recently completed Phase 3 clinical trials of potential new therapies for Alzheimer’s disease (AD). This includes trials of lecanemab (page 1) as well as other treatments. The topline results for lecanemab announced by the trial sponsors are exciting and suggest that lecanemab may slow the progression of AD. The availability of treatments to slow the…
Kirsten
December 7, 2022

EVENT CALENDAR

RESEARCH HEROES

A dollar invested here is like a dollar invested for the rest of the world.

Burton YoungPhilanthropist & Leadership Council Member

Our desire is to do what we can to help find a cure for this disease.

Roger LisabethPhilanthropist & Study Partner

We are at the forefront of finding solutions, but we need the help of the community to make these promising studies as successful as possible.

Joshua Grill, PhDResearcher & Director

Hopefully the research will find cures for people with this disease. That’s why I volunteer and devote time. That’s the whole reason.

Henry WuResearch Participant

I think it’s very important for people to participate in Alzheimer's prevention clinical trials...I have {Alzheimer's} in my family and I’m hopeful that what I’m doing will help people in the future.

Marsha GroveResearch Participant

We are made of memories, and the thought of such a disease capable of disassociating us from the people we love and the world made me want to be a part of a team of researchers who are fighting not only for a better understanding of the disease, but for a cure.

Stefania Forner, PhDResearcher

I began participating in research after my mother passed away with Alzheimer’s in 2000...I feel like I’m contributing. I want to do anything I can to help the research that’s being done.

Linda BenjaminResearch Participant

My family donated {my husband's} brain to research. At every level we were treated with respect and dignity, and we considered it a privilege to be a part of the research to find a cure for this horrible disease.

Dee MaltbyStudy Partner

As I saw my grandfather and so many others lose their memories, it became obvious to me that I should pursue this path and join efforts with a team of admirable researchers to understand and fight this devastating disease.

Alessandra Martini, PhDResearcher

If we can collectively contribute to future generations, who knows what can be achieved.

John BakerResearch Participant